Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Citations Search

Sort By:

Cancer Res. 62, 5485-5488. Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer. 2002

Mendoza, N., Phillips, G.L., Silva, J., Schwall, R., and Wickramasinghe, D.

Notes: In this paper, cell proliferation assays were performed on 22Rv1 cells (human prostate tumor cells) using the CellTiter-Glo™ Luminescent Cell Viability Assay.  Cells were plated at the appropriate density (10,000 cells/well) in a 24-well multiwell plate. Twenty-four hours after plating, cells were exposed to various concentrations of CHS 828 for 24 h. DMSO in PBS was used as a solvent control. After treatment, the medium was removed and replaced with 200 μl of drug-free medium, and cells were incubated further for 48 h. For detection of the luminescent signal, CellTiter-Glo™ reagent was added, and light was measured in the Wallac 1420 Victor, a multilabel, multitask plate counter. (2606)

Expand Full Notes »